Risk Factors for Pancreatic Neuroendocrine Tumors A Clinic-Based Case-Control Study

被引:59
作者
Halfdanarson, Thorvardur R. [1 ]
Bamlet, William R. [3 ]
McWilliams, Robert R. [2 ]
Hobday, Timothy J. [2 ]
Burch, Patrick A. [2 ]
Rabe, Kari G. [2 ]
Petersen, Gloria M. [3 ]
机构
[1] Mayo Clin Arizona, Div Hematol & Med Oncol, Scottsdale, AZ USA
[2] Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN USA
[3] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA
关键词
neuroendocrine tumors; pancreatic neuroendocrine tumors; islet cell tumors; risk factors; carcinoid tumors; ENDOCRINE TUMORS; CANCER; HISTORY; POLYMORPHISMS; PROGNOSIS; SURVIVAL;
D O I
10.1097/MPA.0000000000000234
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Pancreatic neuroendocrine tumors (PNETs) are uncommon, and little is known about their risk factors and association with other cancers. We evaluated whether the following risk factors known to be associated with pancreatic adenocarcinoma are also associated with PNETs: smoking, alcohol use, family history of PNET, and other cancers, and personal history of diabetes as potential risk factors. Methods: Patients with PNETs seen at Mayo Clinic Rochester between 2000 and 2011 were compared with controls seen for a general medical evaluation. Patients and controls completed the same questionnaires. After excluding insulinoma and high-grade PNETs, 355 cases were evaluated, and 309 were matched to 602 controls (2: 1) on age, sex, and region of residence. Results: Personal smoking history was not associated with PNETs. Alcohol use was less common among cases (54% vs 67%, P < 0.001). Cases were more likely to report a family member with sarcoma (P = 0.02), PNET (P = 0.02), gallbladder cancer (P = 0.02), ovarian cancer (P = 0.04), and gastric cancer (P = 0.01). There was no association with other cancers in family members. Diabetes was more commonly reported by cases than controls (19% vs 11%, P < 0.001). Conclusions: With the exception of diabetes, risk factors that are associated with pancreatic adenocarcinoma are not risk factors for PNETs.
引用
收藏
页码:1219 / 1222
页数:4
相关论文
共 19 条
[1]   Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Merkow, Ryan P. ;
Tomlinson, James S. ;
Stewart, Andrew K. ;
Ko, Clifford Y. ;
Talamonti, Mark S. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 205 (04) :558-563
[2]  
CHEN CC, 1994, CANCER EPIDEM BIOMAR, V3, P205
[3]   GLUCOSE-INTOLERANCE IN CARCINOID-SYNDROME [J].
FELDMAN, JM ;
PLONK, JW ;
BIVENS, CH ;
LEBOVITZ, HE .
DIABETES, 1975, 24 (07) :664-671
[4]   Insulinoma [J].
Grant, CS .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (05) :783-798
[5]  
Gullo L, 2003, AM J GASTROENTEROL, V98, P2435
[6]   Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival [J].
Halfdanarson, T. R. ;
Rabe, K. G. ;
Rubin, J. ;
Petersen, G. M. .
ANNALS OF ONCOLOGY, 2008, 19 (10) :1727-1733
[7]   Mitochondrial genetic polymorphisms do not predict survival in patients with pancreatic cancer [J].
Halfdanarson, Thorvardur R. ;
Wang, Liang ;
Bamlet, William R. ;
de Andrade, Mariza ;
McWilliams, Robert R. ;
Cunningham, Julie M. ;
Petersen, Gloria M. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (09) :2512-2513
[8]   Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors [J].
Halfdanarson, Thorvardur R. ;
Rubin, Joseph ;
Farnell, Michael B. ;
Grant, Clive S. ;
Petersen, Gloria M. .
ENDOCRINE-RELATED CANCER, 2008, 15 (02) :409-427
[9]   Risk factors associated with neuroendocrine tumors: A US-based case-control study [J].
Hassan, Manal M. ;
Phan, Alexandria ;
Li, Donghui ;
Dagohoy, Cecile G. ;
Leary, Colleen ;
Yao, James C. .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (04) :867-873
[10]   Family history of cancer and associated risk of developing neuroendocrine tumors: A case-control study [J].
Hassan, Manal M. ;
Phan, Alexandria ;
Li, Donghui ;
Dagohoy, Cecile G. ;
Leary, Colleen ;
Yao, James C. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (04) :959-965